Form 4 for TMDX TransMedics Group, Inc.
Accepted 2024-12-11 00:00:00 ET · period of report 2024-12-09 · accession 0000950170-24-135528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-11 | 2024-12-09 | TMDX | Hernandez Gerardo | CFO | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
| D | 2024-12-11 | 2024-12-09 | TMDX | Hernandez Gerardo | CFO | A - Grant | $0.00 | +18.9K | 18.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | A | A | 12,463 | $0.00 | 12,463 | D | — | — | (F1) Consists of 12,463 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-09 | A | A | 18,922 | $0.00 | 18,922 | D | $69.84 · — to 2034-12-09 | 18,922 Common Stock | (F2) The option vests as to 25% of the shares underlying the option on December 2, 2025 and as to the remaining shares in equal monthly installments over three years thereafter, subject to Reporting Persons' continued service to the Issuer. |